Can Patents Be Wiped Out Because Of A Litigator's Misconduct? Regeneron Asks Supreme Court
Executive Summary
Regeneron challenges Federal Circuit finding that withholding information in discovery constitutes inequitable conduct; district judge orders firm to pay Merus $10.5m in attorneys' fees and costs.
You may also be interested in...
Supreme Court Docket Includes Four Cases Impacting Pharma Industry
Helsinn v. Teva and Merck v. Albrecht directly involve pharma firms while another case addresses America Invents Act. Solicitor General to weigh in on two other cases. Petitions pending on Maryland pricing law, Amgen PCSK9 suit.
Supreme Court Docket Includes Four Cases Impacting Pharma Industry
Helsinn v. Teva and Merck v. Albrecht directly involve pharma firms while another case addresses America Invents Act. Solicitor General to weigh in on two other cases. Petitions pending on Maryland pricing law, Amgen PCSK9 suit.
Regeneron's Patent Pratfall: First Inequitable Conduct, Now Possible Sanctions
After losing patent infringement suit against Merus involving antibody-producing mouse, Regeneron fights ruling that it withheld material information in prosecuting the patent.